Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug regulator, making it the first such vaccine to be cleared in the country, the Japanese drugmaker's India unit said on Monday.
Dengue is a mosquito-borne viral disease and one of the fastest-spreading vector-borne illnesses globally. The World Health Organization reported a record 14.4 million dengue cases and 11,201 deaths worldwide in 2024, including 232,425 cases and 233 deaths in India.